<SEC-DOCUMENT>0001737287-25-000019-index.html : 20250205
<SEC-HEADER>0001737287-25-000019.hdr.sgml : 20250205
<ACCEPTANCE-DATETIME>20250205161547
ACCESSION NUMBER:		0001737287-25-000019
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250203
FILED AS OF DATE:		20250205
DATE AS OF CHANGE:		20250205

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Parker Geoffrey M.
		CENTRAL INDEX KEY:			0001491874
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38693
		FILM NUMBER:		25593494

	MAIL ADDRESS:	
		STREET 1:		15 RIORDAN PLACE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allogene Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001737287
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				823562771
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 457-2700

	MAIL ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wk-form4_1738790139.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wk-form4_1738790139.html

Document 1 - RAW XML: wk-form4_1738790139.xml

</DOCUMENT>
</SEC-DOCUMENT>